Media Contact:
ASHA Media Relations
P.O. Box 13827
Research Triangle Park, NC 27709
(919) 361 - 3124 (voice)
(919) 361 - 8425 (fax)
mediarelations@ashastd.org

12/18/06
Online Hepatitis A and Hepatitis B Education Campaign for Men Who Have Sex with Men

11/29/06
World Aids Day 2006

11/03/06
What's New in Cervical Cancer Prevention

09/08/06
ASHA announces Herpes Education and Counseling Study

08/01/06
ASHA announces promotion of Lynn B. Barclay to President and CEO of ASHA.

08/01/06
FDA approves single-day treatment for recurrent Genital Herpes with Famciclovir (Famvir®). Single dose therapy for treatment of Oral Herpes (cold sores) also approved.

06/28/06
FDA approves HPV Vaccine, Gardisil® (developed by Merck & Co.), the first vaccine against human papillomavirus – HPV – the viruses that cause cervical cancer and genital warts.

06/28/2006
From Washington, D.C. - Report on U.S. Government Policy Deliberations - STD Appropriations in the House, Medical Accuracy Bill and Citizenship Guidelines for Medicaid Eligibility.

06/27/2006
National HIV Testing Day, June 27th.

06/21/06
Condom Use Study Demonstrates Effectiveness Against HPV.

03/28/2006
Get Tested! New data indicates few young Americans tested for common STDs. 79% of new infections are in people age 24 and under.

02/10/2006
ASHA Promotes National Condom Week with Online Campaign.

02/01/2006
AIDS Epidemic Continues to Affect African American Communities - National Black HIV/AIDS Awareness Day Emphasizes Education & Action.

01/10/2006
ASHA Observes Cervical Cancer Awareness Month.